{"title":"Insights into the emerging immune checkpoint NR2F6 in cancer immunity.","authors":"Hayat Miftah, Hamza Benthami, Abdallah Badou","doi":"10.1093/jleuko/qiae260","DOIUrl":null,"url":null,"abstract":"<p><p>NR2F6 has emerged as a key player in immune regulation, especially in cancer immunity. It has indeed been reported that NR2F6 could suppress the anti-tumor immune response, and has therefore been suggested as possible target in cancer immunotherapy. In this review, we will start by describing the complex structure of the NR2F6 gene and its multifaceted biological functions. Then we will examine its expression in distinct immune cells and cancer cells, elucidating its role in cancer progression. Subsequently, we will highlight the predictive significance of NR2F6 for cancer patient outcome, suggesting its possible use as a prognostic biomarker. Finally, we will discuss the emerging potential of NR2F6 as a therapeutic target, presenting novel opportunities for the development of effective cancer immunotherapy strategies.</p>","PeriodicalId":16186,"journal":{"name":"Journal of Leukocyte Biology","volume":" ","pages":""},"PeriodicalIF":3.6000,"publicationDate":"2024-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Leukocyte Biology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/jleuko/qiae260","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
NR2F6 has emerged as a key player in immune regulation, especially in cancer immunity. It has indeed been reported that NR2F6 could suppress the anti-tumor immune response, and has therefore been suggested as possible target in cancer immunotherapy. In this review, we will start by describing the complex structure of the NR2F6 gene and its multifaceted biological functions. Then we will examine its expression in distinct immune cells and cancer cells, elucidating its role in cancer progression. Subsequently, we will highlight the predictive significance of NR2F6 for cancer patient outcome, suggesting its possible use as a prognostic biomarker. Finally, we will discuss the emerging potential of NR2F6 as a therapeutic target, presenting novel opportunities for the development of effective cancer immunotherapy strategies.
期刊介绍：
JLB is a peer-reviewed, academic journal published by the Society for Leukocyte Biology for its members and the community of immunobiologists. The journal publishes papers devoted to the exploration of the cellular and molecular biology of granulocytes, mononuclear phagocytes, lymphocytes, NK cells, and other cells involved in host physiology and defense/resistance against disease. Since all cells in the body can directly or indirectly contribute to the maintenance of the integrity of the organism and restoration of homeostasis through repair, JLB also considers articles involving epithelial, endothelial, fibroblastic, neural, and other somatic cell types participating in host defense. Studies covering pathophysiology, cell development, differentiation and trafficking; fundamental, translational and clinical immunology, inflammation, extracellular mediators and effector molecules; receptors, signal transduction and genes are considered relevant. Research articles and reviews that provide a novel understanding in any of these fields are given priority as well as technical advances related to leukocyte research methods.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
